Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sucampo Pharma Inc (SCMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 504,091
  • Shares Outstanding, K 46,460
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 36-Month Beta 1.40
  • Price/Sales 2.16
  • Price/Cash Flow 4.44
  • Price/Book 2.85

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.40 +15.43%
on 06/16/17
10.89 -0.37%
on 06/23/17
+0.35 (+3.33%)
since 05/23/17
3-Month
9.30 +16.67%
on 04/18/17
11.30 -3.98%
on 03/29/17
+0.10 (+0.93%)
since 03/23/17
52-Week
9.30 +16.67%
on 04/18/17
17.55 -38.18%
on 11/30/16
-0.10 (-0.91%)
since 06/23/16

Most Recent Stories

More News
29.3% Return Seen to Date on SmarTrend Sucampo Pharmaceuticals Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 6 months, Sucampo Pharmaceuticals has returned 29.34% as of today's recent...

SCMP : 10.85 (+1.40%)
Sucampo Pharmaceuticals Shares Down 27.9% Since SmarTrend's Sell Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 6 months, Sucampo Pharmaceuticals has returned 27.90% as of today's recent...

SCMP : 10.85 (+1.40%)
Why Is Sucampo (SCMP) Up 1.5% Since the Last Earnings Report?

Sucampo (SCMP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SCMP : 10.85 (+1.40%)
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2017 Global Healthcare Conference

Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Jefferies 2017 Global Healthcare Conference...

SCMP : 10.85 (+1.40%)
Sucampo Pharmaceuticals Shares Down 21.8% Since SmarTrend's Sell Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 5 months, Sucampo Pharmaceuticals has returned 21.77% as of today's recent...

SCMP : 10.85 (+1.40%)
Sucampo Pharmaceuticals Has Returned 26.8% Since SmarTrend Recommendation (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 5 months, Sucampo Pharmaceuticals has returned 26.82% as of today's recent...

SCMP : 10.85 (+1.40%)
Investor Network: Sucampo Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 3, 2017 / Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) will be discussing their earnings results in their Q1 Earnings Call to be held May 3, 2017 at 8:30 AM Eastern Time....

SCMP : 10.85 (+1.40%)
Sucampo Reports First Quarter 2017 Financial Results

Continued Revenue Growth

SCMP : 10.85 (+1.40%)
Sucampo Pharmaceuticals Shares Down 30.8% Since SmarTrend's Sell Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 4 months, Sucampo Pharmaceuticals has returned 30.79% as of today's recent...

SCMP : 10.85 (+1.40%)
Sucampo Announces First Quarter 2017 Earnings Call

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter 2017 financial results teleconference and webcast at 8:30...

SCMP : 10.85 (+1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones...

See More

Support & Resistance

2nd Resistance Point 11.14
1st Resistance Point 10.99
Last Price 10.85
1st Support Level 10.60
2nd Support Level 10.36

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.